Other
Pregnant Women
0
Pipeline Programs↗
14
Active Trials↗
8
Companies Involved↗
Pregnant Women is an early-stage landscape with 0 programs across 8 companies. The most active players are Pfizer, GSK, Johnson & Johnson.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
114
clinical trials
Completed74 · 65%
Unknown status12 · 11%
Terminated10 · 9%
Not yet recruiting6 · 5%
Recruiting5 · 4%
Withdrawn4 · 4%
Other3 · 3%
Clinical Trials
Trial Activity
114 trials
A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women
Recruiting·—·Phase 2/3·NCT06592586·338 enrolled
Comparison in Cervical Length and Prolongation of Gestation Age on Vaginal Progesterone Administration to Pregnant Women After the Acute Phase of Threatened Preterm Birth
Active, not recruiting·—·N/A·NCT06975943·48 enrolled
Pertussis Vaccination Among HIV-infected and HIV-uninfected Pregnant Women
Active, not recruiting·—·Phase 4·NCT05264662·511 enrolled
Effect of Kinesiotape on Emesis in Pregnant Women
Not yet recruiting·—·N/A·NCT06625632·50 enrolled
GBS-NN/NN2 (50 µg of Each Fusion Protein [GBS-NN and GBS-NN2] in Combination With 500 µg Aluminum as Alhydrogel®) Given With and Without the Tdap Vaccine in Healthy Non-pregnant Women 18 to 49 Years of Age
Not yet recruiting·—·Phase 2/3·NCT06494475·564 enrolled
Page 1 of 8
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)